Back to top

Abbott Laboratories (ABT) Gets a Buy from Raymond James

In a report released on July 17, Jayson Bedford from Raymond James maintained a Buy rating on Abbott Laboratories. The company’s shares closed last...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Abbott Laboratories (ABT)